Three new #GLP 1 drugs for obesity treatment2 injectables and 1 pillmay receive FDA approval this year. Here's how high dose semaglutide, cagrilintide plus semaglutide, and orforglipron performed in phase 3 trials. Cagrilintide Semaglutide Blend 5+5mg for Sale Cagri Sema Beyond semaglutide and tirzepatide, where might we find the next GLP 1 based advances in #weightloss #obesity Take a look at the slope of the lines for the combination of cagrilintide + semaglutide and Once weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double blind, placebo controlled and active controlled, dose finding phase 2 trial UCL Discovery